Planet 13 Holdings (PLNH) Long-Term Deferred Tax (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Long-Term Deferred Tax of $1.8 million for Q1 2026, up 38.93% year-over-year from $1.3 million in Q1 2025, and down 0.83% quarter-over-quarter from $1.8 million in Q4 2025.
Planet 13 Holdings (PLNH) Long-Term Deferred Tax (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Long-Term Deferred Tax for 6 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 38.93% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 38.93% YoY), while the FY2025 annual figure was $1.8 million, up 100.63% from the prior year.
- Long-Term Deferred Tax retreated to $1.8 million in Q1 2026 per PLNH's latest filing, from $1.8 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $2.4 million in Q3 2025 and bottomed at $174157.0 in Q1 2022.
- Historically, Long-Term Deferred Tax has averaged $849800.2 across 5 years, with a median of $725196.0 in 2024.
- Annual changes were most pronounced in 2024 — Long-Term Deferred Tax rose 26.98% — and 2025, when it jumped 227.17%.
- Planet 13 Holdings' Long-Term Deferred Tax stood at $346257.0 in 2022, then soared by 103.91% to $706038.0 in 2023, then rose by 26.98% to $896525.0 in 2024, then soared by 100.63% to $1.8 million in 2025, then retreated by 0.83% to $1.8 million in 2026.
- Business Quant data shows PLNH's Long-Term Deferred Tax at $1.8 million in Q1 2026, $1.8 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.99 Mn |
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 896,525.00 |
| Sep 30, 2024 | 729,435.00 |
| Jun 30, 2024 | 747,619.00 |
| Mar 31, 2024 | 725,196.00 |
| Dec 31, 2023 | 706,038.00 |
| Sep 30, 2023 | 350,001.00 |
| Jun 30, 2023 | 318,294.00 |
| Mar 31, 2023 | 276,088.00 |
| Dec 31, 2022 | 346,257.00 |
| Sep 30, 2022 | 206,421.00 |
| Jun 30, 2022 | 190,432.00 |
| Mar 31, 2022 | 174,157.00 |
| Dec 31, 2021 | 162,804.00 |